[EN] NOVEL 4-BENZHYDRYL-TETRAHYDRO-PYRIDINE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS<br/>[FR] NOUVEAUX DÉRIVÉES DE LA 4-BENZHYDRYL-TETRAHYDRO-PYRIDINE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA RECAPTURE DES NEUROTRANSMETTEURS MONOAMINES
申请人:NEUROSEARCH AS
公开号:WO2009109518A1
公开(公告)日:2009-09-11
This invention relates to novel 4-benzhydryl-tetrahydro-pyridine derivatives of Formula (I), any of its stereoisomers or any mixture of its stereoisomers, or an N-oxide thereof, or a pharmaceutically acceptable salt thereof, wherein Ra represents hydrogen or C1-6-alkyl; Rband Rc independent of each other represent a phenyl group, which phenyl group is optionally substituted with one or more substituents independently selected from the group consisting of halo, trifluoromethyl, trifluoromethoxy, cyano, C1-6-alkoxy and methylenedioxo useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
这项发明涉及公式(I)的新型4-苄基四氢吡啶衍生物,其立体异构体中的任何一种或其立体异构体的任何混合物,或其N-氧化物,或其药学上可接受的盐,其中Ra代表氢或C1-6-烷基;Rb和Rc彼此独立地代表苯基,该苯基可以选择性地被一个或多个取代基取代,这些取代基独立地选自卤素、三氟甲基、三氟甲氧基、氰基、C1-6-烷氧基和亚甲二氧基,用作单胺神经递质再摄取抑制剂。在其他方面,该发明涉及将这些化合物用于治疗方法以及包含该发明化合物的药物组合物。